Skip to main content
SpringerLink
Log in

Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

First- and second-generation antihistamines are known to produce different degrees of sedation. However, a few studies have shown that the H1-antagonist fexofenadine produces mild stimulating effects. One hypothesis suggests that this is due to fexofenadine producing an increase in dopamine levels by blocking the dopamine transporter.

Objective

In this study, it was investigated whether a high dose of fexofenadine blocks the dopamine transporter in the striatum. In addition, the effect of fexofenadine on cognitive performance and motor impulsivity was investigated.

Methods

Sixteen healthy subjects were given either placebo or fexofenadine 360 mg. The binding potential of N-w-fluoropropyl-2β-carbomethoxy-3β-[4-iodophenyl] nortropane ([123I]FP-CIT) was measured using single-photon emission computed tomography (SPECT). Cognitive performance was measured in 40 subjects (20 placebo, 20 fexofenadine) using a digit symbol substitution test (DSST) and a stop signal task. In addition, subjective and physiological effects of fexofenadine were observed.

Results

The SPECT data demonstrated that there was no difference in the binding potential of FP-CIT at the dopamine transporter in the striatum between the placebo- and fexofenadine-treated subjects. The behavioral results showed that fexofenadine improved performance on the DSST at T max of the drug. Fexofenadine did not affect motor impulsivity, subjective experience, or physiological measures.

Conclusion

No evidence was provided to support the hypothesis that fexofenadine stimulates performance by blocking the dopamine transporter. The behavioral data suggest that a high dose of fexofenadine can stimulate performance in cognitive tasks.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Blokland A, Sik A, Lieben C (2005) Evaluation of DOI, 8-OH-DPAT, eticlopride and amphetamine on impulsive responding in a reaction time task in rats. Behav Pharmacol 16:93–100

    Article  PubMed  CAS  Google Scholar 

  • Cami J, Farre M, Mas M, Roset PN, Poudevida S, Mas A, San L, de la Torre R (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine (“ecstasy”): psychomotor performance and subjective effects. J Clin Psychopharmacol 20:455–466

    Article  PubMed  CAS  Google Scholar 

  • Chen N, Reith ME (2000) Structure and function of the dopamine transporter. Eur J Pharmacol 405:329–339

    Article  PubMed  CAS  Google Scholar 

  • de Wit H, Enggasser JL, Richards JB (2002) Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27:813–825

    Article  PubMed  Google Scholar 

  • Dringenberg HC, de Souza-Silva MA, Schwarting RK, Huston JP (1998) Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade. Naunyn Schmiedebergs Arch Pharmacol 358:423–429

    Article  PubMed  CAS  Google Scholar 

  • Fillmore MT, Rush CR, Hays L (2002) Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend 67:157–167

    Article  PubMed  CAS  Google Scholar 

  • Fillmore MT, Rush CR, Marczinski CA (2003) Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend 71:143–152

    Article  PubMed  CAS  Google Scholar 

  • Haga JL, Baker RW, Rush CR (2003) Behavioral and physiological effects of cocaine in humans following triazolam. Pharmacol Biochem Behav 76:383–392

    Article  PubMed  CAS  Google Scholar 

  • Higgins ST, Rush CR, Bickel WK, Hughes JR, Lynn M, Capeless MA (1993) Acute behavioral and cardiac effects of cocaine and alcohol combinations in humans. Psychopharmacology (Berl) 111:285–294

    Article  CAS  Google Scholar 

  • Holdstock L, de Wit H (2001) Individual differences in responses to ethanol and d-amphetamine: a within-subject study. Alcohol Clin Exp Res 25:540–548

    Article  PubMed  CAS  Google Scholar 

  • Kay GG (2000) The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 105:S622–S627

    Article  PubMed  CAS  Google Scholar 

  • Korotkova TM, Haas HL, Brown RE (2002) Histamine excites GABAergic cells in the rat substantia nigra and ventral tegmental area in vitro. Neurosci Lett 320:133–136

    Article  PubMed  CAS  Google Scholar 

  • Lamers CT, Ramaekers JG, Muntjewerff ND, Sikkema KL, Samyn N, Read NL, Brookhuis KA, Riedel WJ (2003) Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance. J Psychopharmacol 17:379–387

    Article  PubMed  CAS  Google Scholar 

  • Lapa GB, Mathews TA, Harp J, Budygin EA, Jones SR (2005) Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties. Eur J Pharmacol 506:237–240

    Article  PubMed  CAS  Google Scholar 

  • Leshner AI, Koob GF (1999) Drugs of abuse and the brain. Proc Assoc Am Physicians 111:99–108

    Article  PubMed  CAS  Google Scholar 

  • Logan GD (1994) On the ability to inhibit thought and action. In: Dagenbach D, Carr TH (eds) Inhibitory processes in attention, memory and language. Academic, San Diego, pp 189–239

    Google Scholar 

  • Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 12:245–258

    PubMed  CAS  Google Scholar 

  • Matsunaga K, Sato T, Shuto H, Tsuruta Y, Suemaru K, Gomita Y, Oishi R (1998) Inhibition of neuronal dopamine uptake by some antiallergic drugs. Eur J Pharmacol 350:165–169

    Article  PubMed  CAS  Google Scholar 

  • Mattila MJ, Kuitunen T, Pletan Y (1992) Lack of pharmacodynamic and pharmacokinetic interactions of the antihistamine ebastine with ethanol in healthy subjects. Eur J Clin Pharmacol 43:179–184

    Article  PubMed  CAS  Google Scholar 

  • Meltzer EO, Casale TB, Nathan RA, Thompson AK (1999) Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 83:311–317

    Article  PubMed  CAS  Google Scholar 

  • Moskowitz H, Burns MB (1988) Effects of terfenadine, diphenhydramine, and placebo on skills performance. Cutis 42:14–18

    PubMed  CAS  Google Scholar 

  • O’Hanlon JF, Ramaekers JG (1995) Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989–94. Allergy 50:234–342

    Article  PubMed  CAS  Google Scholar 

  • Oishi R, Shishido S, Yamori M, Saeki K (1994) Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol 349:140–144

    Article  PubMed  CAS  Google Scholar 

  • Rombaut NEI, Hindmarch I (1994) Psychometric aspects of antihistamines: a review. Hum Psychopharmacol 9:157–169

    Article  CAS  Google Scholar 

  • Sharif NA, Su SX, Yanni JM (1994) Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies. J Ocul Pharmacol 10:653–664

    Article  PubMed  CAS  Google Scholar 

  • Simons FE (1994) H1-receptor antagonists. Comparative tolerability and safety. Drug Saf 10:350–380

    Article  PubMed  CAS  Google Scholar 

  • Tashiro M, Mochizuki H, Iwabuchi K, Sakurada Y, Itoh M, Watanabe T, Yanai K (2002) Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci 72:409–414

    Article  PubMed  CAS  Google Scholar 

  • Theunissen EL, Jonkman LM, Kuypers KPC, Ramaekers JG (2006a) Stimulating effects of fexofenadine under high workload conditions. A combined neurophysiological and behavioral approach. J Psychopharmacol (in press)

  • Theunissen EL, Vermeeren A, Vuurman EFPM, Ramaekers JG (2006b) Stimulating effects of H1-antagonists. Curr Pharm Des (in press)

  • Vermeeren A (2003) Hypnotics and antihistamines: effects on cognitive functions and driving performance. Thesis, Maastricht University, p 224

  • Vermeeren A, O’Hanlon JF (1998) Fexofenadine’s effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol 101:306–311

    Article  PubMed  CAS  Google Scholar 

  • Vuurman EFPM, Rikken GH, Muntjewerff ND, de Halleux F, Ramaekers JG (2004) Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. Eur J Clin Pharmacol 60:307–313

    Article  PubMed  CAS  Google Scholar 

  • Wechsler D (1981) A manual for the Wechsler adult intelligence scale (revised). Psychological Corporation, San Antonio

    Google Scholar 

  • Weight ML, Ridley RM, Baker HF (1980) The effect of amphetamine on delayed response performance in the monkey. Pharmacol Biochem Behav 12:861–864

    Article  PubMed  CAS  Google Scholar 

  • Wise RA, Rompre PP (1989) Brain dopamine and reward. Annu Rev Psychol 40:191–225

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Experimental Psychopharmacology Unit, Faculty of Medicine, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands

    Jeroen A. van Deursen

  2. Department of Nuclear Medicine, University Hospital Maastricht, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands

    Marinus J. P. G. van Kroonenburgh & Ciska Blom-Coenjaerts

  3. Experimental Psychopharmacology Unit, Department of Neurocognition, Faculty of Psychology, University of Maastricht, P.O. Box 616, 6200 MD, Maastricht, The Netherlands

    Eef L. Theunissen & Johannes G. Ramaekers

Authors
  1. Eef L. Theunissen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marinus J. P. G. van Kroonenburgh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeroen A. van Deursen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ciska Blom-Coenjaerts
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Johannes G. Ramaekers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eef L. Theunissen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Theunissen, E.L., van Kroonenburgh, M.J.P.G., van Deursen, J.A. et al. Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis. Psychopharmacology 187, 95–102 (2006). https://doi.org/10.1007/s00213-006-0406-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-006-0406-3

Keywords

Search

Navigation